Explore more publications!
Health & Wellness Today New York
Got News to Share?

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on January 30, 2026

French Optical Fashion, Inc Debuts Designer Eyewear + Precision Lenses for Optometrist NYC Patients
Jan. 30, 2026

French Optical Fashion, Inc Debuts Designer Eyewear + Precision Lenses for Optometrist NYC Patients

Indeterminate EIN Presswire
JUARA Introduces the New Radiance Plumping Serum Alongside Valentine’s Day Sale
Jan. 30, 2026

JUARA Introduces the New Radiance Plumping Serum Alongside Valentine’s Day Sale

Indeterminate EIN Presswire
Creative Bioarray Unveils Comprehensive In Vitro Hepatotoxicity Testing Services
Jan. 30, 2026

Creative Bioarray Unveils Comprehensive In Vitro Hepatotoxicity Testing Services

Indeterminate EIN Presswire
Holistic Health Practitioner Xiomara Hoey of Xiomara Empowered Health Recently Featured on Close Up Radio
Jan. 30, 2026

Holistic Health Practitioner Xiomara Hoey of Xiomara Empowered Health Recently Featured on Close Up Radio

Indeterminate EIN Presswire
Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles
Jan. 30, 2026

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Indeterminate GlobeNewswire
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
Jan. 30, 2026

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

Indeterminate GlobeNewswire
NEOMED earns accreditation for new Certified Mental Health Assistant program and becomes first in the nation to offer the innovative degree
Jan. 30, 2026

NEOMED earns accreditation for new Certified Mental Health Assistant program and becomes first in the nation to offer the innovative degree

Indeterminate GlobeNewswire
Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
Jan. 30, 2026

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Jan. 30, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Jan. 30, 2026

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire
NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise
Jan. 30, 2026

NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise

Indeterminate GlobeNewswire
Olema Oncology Announces Departure of Chief Operating and Financial Officer
Jan. 30, 2026

Olema Oncology Announces Departure of Chief Operating and Financial Officer

Indeterminate GlobeNewswire
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
Jan. 30, 2026

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

Indeterminate GlobeNewswire
Strategic Innovation in Antibody Engineering: Creative Biolabs Addresses Key Challenges in ADCC and Fc Functionality
Jan. 30, 2026

Strategic Innovation in Antibody Engineering: Creative Biolabs Addresses Key Challenges in ADCC and Fc Functionality

Indeterminate EIN Presswire
Dr. Christina Rahm and Clayton Thomas of The ROOT Brands Attend World Economic Forum Annual Meeting 2026 in Davos
Jan. 30, 2026

Dr. Christina Rahm and Clayton Thomas of The ROOT Brands Attend World Economic Forum Annual Meeting 2026 in Davos

Indeterminate GlobeNewswire
CrazyBulk: SARM Alternatives for Bulking, Strength and Performance or Just Hype?
Jan. 30, 2026

CrazyBulk: SARM Alternatives for Bulking, Strength and Performance or Just Hype?

Indeterminate GlobeNewswire
Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
Jan. 30, 2026

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

Indeterminate GlobeNewswire
Global Virus Network Statement on Nipah Virus Outbreak
Jan. 30, 2026

Global Virus Network Statement on Nipah Virus Outbreak

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

Indeterminate GlobeNewswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions